Marksans Pharma Limited said that its fully-owned subsidiary Relonchem Limited has secured market authorization from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for Loperamide 2mg hard capsules.

The Indian pharma company will manufacture the Loperamide 2mg hard capsules at its oral dosage facility in Goa. The facility has the approval of the UK MHRA.

Loperamide is used for reducing the frequency of diarrhea.

  diarrhea, Loperamide, Marksans Pharma, Relonchem Limited, UK Medicines and Healthcare Products Regulatory Agency, UK MHRA, United Kingdom